Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity E.m.ld Regulatory News (FEML)

Share Price Information for Fidelity E.m.ld (FEML)

Share Price is delayed by 15 minutes
Get Live Data
1,400.00    -12.00 (-0.85%)
Bid:
1,398.00
Ask:
1,404.00
Spread: 6.00 (0.429%)
Market Cap: £565.34m
FEML Live PriceLast checked at - London Stock Exchange

Intraday Fidelity E.m.ld Share Chart

Net Asset Value(s)

15 Sep 2025 07:36

RNS Number : 3084Z
Fidelity Emerging Markets Limited
15 September 2025
 
Fidelity Emerging Markets Limited 
15 September 2025 
  
The Directors of Fidelity Emerging Markets Limited announce the following unaudited estimates as at 12 September 2025:
  
NAV (ex income)
961.17p
NAV (cum income)
991.21p
Total Assets (ex income)
£614.279 million
Total Assets (cum income)
£633.476 million
  
  
Enquiries:  
  
Fidelity Investment International 
Phone + 44 ( 0) 1737 837846 
  
END  
  
Fidelity Emerging Markets Limited 
Source: Fidelity Emerging Markets Limited 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQELBFEKLXBBE
Date   Source Headline
24th Mar 20255:29 pmPRNTransaction in Own Shares
24th Mar 202512:52 pmRNSNet Asset Value(s)
21st Mar 20255:24 pmPRNTransaction in Own Shares
21st Mar 202512:14 pmRNSNet Asset Value(s)
20th Mar 20255:22 pmPRNTransaction in Own Shares
20th Mar 202512:01 pmRNSNet Asset Value(s)
19th Mar 20255:10 pmPRNTransaction in Own Shares
19th Mar 202512:04 pmRNSNet Asset Value(s)
18th Mar 20255:12 pmPRNTransaction in Own Shares
18th Mar 202511:58 amRNSNet Asset Value(s)
17th Mar 20255:13 pmPRNTransaction in Own Shares
17th Mar 202512:59 pmRNSNet Asset Value(s)
14th Mar 20255:06 pmPRNTransaction in Own Shares
14th Mar 202512:24 pmRNSNet Asset Value(s)
13th Mar 20255:17 pmPRNTransaction in Own Shares
13th Mar 202512:29 pmRNSNet Asset Value(s)
13th Mar 20257:00 amPRNHalf-year Report
12th Mar 202512:56 pmRNSNet Asset Value(s)
11th Mar 20255:16 pmPRNTransaction in Own Shares
11th Mar 202512:42 pmRNSNet Asset Value(s)
10th Mar 20255:23 pmPRNTransaction in Own Shares
10th Mar 202512:15 pmRNSNet Asset Value(s)
7th Mar 20255:24 pmPRNTransaction in Own Shares
7th Mar 202512:47 pmRNSNet Asset Value(s)
6th Mar 20255:08 pmPRNTransaction in Own Shares
6th Mar 202512:51 pmRNSNet Asset Value(s)
5th Mar 20255:42 pmPRNTransaction in Own Shares
5th Mar 202512:11 pmRNSNet Asset Value(s)
4th Mar 20255:33 pmPRNTransaction in Own Shares
4th Mar 202512:16 pmRNSNet Asset Value(s)
3rd Mar 20256:06 pmPRNTotal Voting Rights
3rd Mar 202512:58 pmRNSNet Asset Value(s)
28th Feb 20255:44 pmPRNTransaction in Own Shares
28th Feb 202512:50 pmRNSNet Asset Value(s)
27th Feb 20255:37 pmPRNTransaction in Own Shares
27th Feb 20251:02 pmRNSNet Asset Value(s)
27th Feb 202510:16 amPRNMonthly Factsheet
26th Feb 20255:21 pmPRNTransaction in Own Shares
26th Feb 202512:53 pmRNSNet Asset Value(s)
25th Feb 20255:18 pmPRNTransaction in Own Shares
25th Feb 202512:35 pmRNSNet Asset Value(s)
24th Feb 202512:34 pmRNSNet Asset Value(s)
21st Feb 202512:01 pmRNSNet Asset Value(s)
20th Feb 20255:40 pmPRNTransaction in Own Shares
20th Feb 202512:17 pmRNSNet Asset Value(s)
19th Feb 20255:29 pmPRNTransaction in Own Shares
19th Feb 202512:23 pmRNSNet Asset Value(s)
18th Feb 20255:02 pmPRNTransaction in Own Shares
18th Feb 20253:58 pmPRNHolding(s) in Company
18th Feb 202512:07 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.